What are the guidelines for monitoring calcitonin levels and performing thyroid ultrasound in a 1-year-old child with RET (Ret proto-oncogene) 634F mutation to screen for medullary thyroid carcinoma (MTC)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Monitoring Guidelines for a 1-Year-Old Child with RET634F Mutation

For a 1-year-old child with RET634F mutation, annual calcitonin screening and thyroid ultrasound should begin at 3 years of age, with thyroidectomy recommended by age 5 or when calcitonin levels become elevated. 1

Risk Classification and Monitoring Approach

The RET634F mutation is classified as a "high-risk" mutation (codon 634) that requires structured surveillance and timely intervention:

Initial Assessment (Current Age: 1 Year)

  • No immediate calcitonin testing or ultrasound is recommended at this age
  • Document family history of MTC aggressiveness
  • Genetic counseling for family members

Monitoring Schedule

  1. Begin annual screening at age 3 years 1, 2:

    • Annual serum calcitonin measurement
    • Annual thyroid ultrasound
    • Continue until thyroidectomy is performed
  2. Proceed to thyroidectomy when either:

    • Calcitonin levels show an upward trend or become elevated
    • Ultrasound identifies thyroid abnormalities
    • Child reaches 5 years of age (even with normal tests) 1, 2

Important Considerations for Calcitonin Testing

  • Physiological considerations: Calcitonin levels in infancy may be as high as 50 pg/mL with a decreasing trend over the first three years of life, limiting the utility of this marker in very young children 1
  • Interpretation challenges: Age-dependent reference ranges should be used for children 3
  • Testing method: Electro chemiluminescence immuno-assay (ECLIA) has been shown to be effective for early MTC detection in children with high-risk RET mutations 4
  • Stimulation testing: Calcium stimulation testing may be considered in cases where basal calcitonin results are equivocal 5

Ultrasound Considerations

  • Ultrasound appears to be less sensitive than calcitonin for diagnosis of MTC and should not be used alone to exclude malignancy or delay surgery 1
  • Ultrasound serves multiple purposes:
    • Document normal gland in at-risk individuals
    • Pre-operative staging when surgery is planned
    • Detection of cervical adenopathy

Additional Monitoring

  • Pheochromocytoma screening: Should be performed annually, as codon 634 variants are associated with higher risks of pheochromocytoma 1, 2
  • Hyperparathyroidism screening: Serum calcium and PTH monitoring should be performed annually, as codon 634 variants are associated with higher risks of hyperparathyroidism 1, 2

Surgical Planning

When thyroidectomy becomes indicated:

  • Refer to a surgeon experienced in pediatric thyroid surgery 1
  • Preoperative staging with ultrasound is essential to identify regional lymphadenopathy 1
  • Total thyroidectomy by age 5 years is recommended for high-risk mutations like codon 634 1, 2

Common Pitfalls to Avoid

  • Delaying surveillance: Starting monitoring too late can miss early disease
  • Over-reliance on ultrasound: Remember that calcitonin is more sensitive for early detection
  • Ignoring family history: The aggressiveness of MTC in other family members with the same mutation should inform management decisions
  • Failure to screen for associated conditions: Pheochromocytoma must be ruled out before any thyroid surgery 2

By following these guidelines, early detection of medullary thyroid carcinoma can be achieved, allowing for timely intervention and improved outcomes for children with RET634F mutations.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Medullary Thyroid Carcinoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Detection of early stage medullary thyroid carcinoma by measuring serum calcitonin using an electro chemiluminescence immuno-assay: A case report of a young Japanese woman with a high-risk RET mutation.

Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology, 2017

Research

Calcitonin as Biomarker for the Medullary Thyroid Carcinoma.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.